f-star Biotechnologische Forschungs- und Entwicklungsgesellschaft

Loading...

f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.

About f-star Biotechnologische Forschungs- und Entwicklungsgesellschaft

f-star is an antibody engineering company based in Vienna, Austria. The company develops improved therapeutic antibodies and antibody fragments based on its Modular Antibody Technology, which allows the introduction of additional binding sites into antibodies and antibody fragments by engineering the non-CDR loops of constant or variable domains. Using Modular Antibody Technology, antibody fragments with antibody functionality and long half life but much smaller size (Fcab™) or full antibodies with additional functionality (mAb²) can be created.

Facts about f-star Biotechnologische Forschungs- und Entwicklungsgesellschaft
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of f-star Biotechnologische Forschungs- und Entwicklungsgesellschaft

Here you will find f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous